XTLB - XTL BIOPHARMACEUTICALS LTD
Previous close
1.86
0 0%
Share volume: 25
Last Updated: Wed 08 Jan 2025 03:47:21 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$1.86
0.00
0.00%
Summary score
15%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.08%
Return on assets
-4.17%
Return on sales
0%
Return on invested capital
6640.15%
Total debt ratio
19.48%
Debt ratio change over timeo
-1.1%
Current Ratio
28.65%
Quick Ratio
0%
Cash Position Ratio
14.36%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-0.44%
Return on assets
-2.17%
Return on sales
0%
Return on invested capital
298.68%
Total debt ratio
2.35%
Debt ratio change over timeo
-1%
Current Ratio
42.04%
Quick Ratio
0%
Cash Position Ratio
20.24%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-15.65%
Return on assets
-2.42%
Return on sales
0%
Return on invested capital
-695.44%
Total debt ratio
2.41%
Debt ratio change over time
-1%
Current Ratio
39.54%
Quick Ratio
0%
Cash Position Ratio
23.21%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-144.7%
Return on assets
-90.34%
Return on sales
0%
Return on invested capital
-904.24%
Total debt ratio
-110.16%
Debt ratio change over time
-1.1%
Current Ratio
-75.84%
Quick Ratio
0%
Cash Position Ratio
-13.34%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XTLB | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -6.08% | 5.89% | 9.6% | 6.44% |
| Return on assets | -4.17% | 3.81% | 3.52% | 2.82% |
| Return on sales | 0% | 33.24% | 43.6% | 16.79% |
| Return on invested capital | 6640.15% | 4.43% | 8.45% | 2427.78% |
| Profitability | 25% | 59% | 73% | 54% |
| Total debt ratio | 19.48% | 99.62% | 70.37% | 41.17% |
| Debt ratio change over time | -1.1% | 15.49% | 5.02% | 0.12% |
| Dept financing | 5% | 50% | 26% | 11% |
| Current Ratio | 42.04% | 1.02% | 2.84% | 3.6% |
| Quick Ratio | 0% | 0.91% | 2.57% | 3.48% |
| Cash Position Ratio | 20.24% | 0.44% | 0.67% | 2.51% |
| Liquididy | 50% | 10% | 30% | 28% |
| Short-term ratios | XTLB | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -0.44% | -10.21% | 18% | 11.75% |
| Return on assets | -2.17% | 3.12% | 3.99% | 2.87% |
| Return on sales | 0% | 21.95% | 42.62% | 21.74% |
| Return on invested capital | 298.68% | 3.21% | 12.03% | 42.93% |
| Profitability | 25% | 33% | 76% | 51% |
| Total debt ratio | 2.35% | 114.21% | 81.93% | 28.7% |
| Debt ratio change over time | -1% | 17.86% | 5.8% | -0.35% |
| Dept financing | 1% | 50% | 26% | 6% |
| Current Ratio | 42.04% | 1.02% | 2.84% | 3.6% |
| Quick Ratio | 0% | 0.91% | 2.57% | 3.48% |
| Cash Position Ratio | 20.24% | 0.44% | 0.67% | 2.51% |
| Liquididy | 50% | 8% | 21% | 30% |